BCRX Market Cap & Key Metrics
BioCryst Pharmaceuticals, Inc.
$8.05
-$0.02(-0.25%)
39
Overall
60
Value
10
Tech
47
Quality
Market Cap
$2.06B
Volume
5.64M
52W Range
$6.00 - $11.22
Target Price
$20.45
BCRX market cap is $2.06B. This page lists BioCryst Pharmaceuticals, Inc.'s P/E ratio, EPS estimates, dividend yield, payout ratio and MarketXLS scores.
BCRX Key Metrics
- Market cap
- $2.06B
- EPS estimate, current year
- $-2.28
- EPS growth, 3-year
- +43.38%
- Value score
- 60
- Quality score
- 47
- Technical score
- 10
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $874.84M | $450.71M | $331.41M | $270.83M | $157.17M |
| EBITDA | $347.65M | $12.81M | -$116.33M | -$145.63M | -$67.54M |
| EPS | $1.26 | $-0.43 | $-1.18 | $-1.33 | $-1.03 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | BCRX | $8.05 | -0.2% | 5.64M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get BioCryst Pharmaceuticals, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW